INS and Hypoglycemia: Despite a modest reduction in receptor potency relative to native dasiglucagon, this approach provides significant prophylactic protection in a streptozotocin-induced diabetic mouse model of insulin overdose, rescuing mice from hypoglycemia and eliminating mortality events.